CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 4 Gift Director gave 850 shares (gift)
- 4 Open-market sale EVP, Research and Development sold 1,000 shares at $350.00 ($350,000)
- 4 Shares withheld for taxes EVP, Human Resources gave up 163 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 880 shares (grant or award)
- 4 Grant or award Director acquired 880 shares (grant or award)
- 4 Grant or award Director acquired 880 shares (grant or award)
- 4 Grant or award Director acquired 880 shares (grant or award)
- 4 Grant or award Director acquired 880 shares (grant or award)
- 4 Grant or award Director acquired 880 shares (grant or award)
- 4 Grant or award Director acquired 1,450 shares (grant or award)
- 4 Grant or award Director acquired 880 shares (grant or award)
- 4 Grant or award Director acquired 880 shares (grant or award)
- 4 Grant or award Director acquired 880 shares (grant or award)
- 4 Shares withheld for taxes EVP, Research and Development gave up 1,076 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 750 shares (to pay taxes)
- 4 Open-market buy Director bought 48,000 shares at $269.91 ($12,955,680)
- 4 Shares withheld for taxes EVP Pharmaceutical Oper & Tech gave up 642 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
Page 20 of 86 · 1,714 filings